Category: Professional Posters
Albumin is widely used in the critical care units although its approved indications are limited. In 2016, medication use evaluation (MUE) was conducted for appropriate use of albumin at Tawam hospital. The MUE prompted albumin prescribing interventions due to high cost in the hospital with a significant increase in critical care units.
Method: After the MUE analysis in 2016, critical care management-initiated communication and discussions regarding prescribing pattern versus evidence-based practice. Albumin guidelines were implemented in collaboration with clinical pharmacy. Post-intervention data of 2017 was pulled retrospectively using a hospital information system (HIS).
Results: The data showed a decrease in inappropriate prescribing as per the guidelines especially in critical care units. The cost of Albumin dropped by 128,808 USD (16%), with 73% (94,139 USD) reduction achieved in the critical care units.
Conclusion: A significant change of albumin prescribing practice was observed after albumin guidelines implementation and evidence-based practice awareness. Pharmacy verification based on the albumin guidelines has an impact on albumin use optimization and cost minimization. Reference: Tawam hospital information system data.